Global Wilson's Disease Drugs Market 2023-2027

Description

List of Tables

The Wilson's disease drugs market is forecasted to grow by USD 179.97 mn during 2022-2027, accelerating at a CAGR of 6.32% during the forecast period. The report on the Wilson's disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness among people for disease treatment, increase in the prevalence of Wilson's disease, and rise in adoption of early diagnosis.

Technavio's Wilson's disease drugs market is segmented as below:

By Product

Chelators
Minerals

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing prevalence of chronic pain as one of the prime reasons driving the Wilson's disease drugs market growth during the next few years. Also, increasing introduction of patient assistance programs and advancement in research and development activities for drug development will lead to sizable demand in the market.

The report on the Wilson's disease drugs market covers the following areas:

Wilson's disease drugs market sizing
Wilson's disease drugs market forecast
Wilson's disease drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Wilson's disease drugs market vendors that include ANI Pharmaceuticals Inc., Apotex Inc., AstraZeneca Plc, Bausch Health Co. Inc., Breckenridge Pharmaceutical Inc., Dr Reddys Laboratories Ltd., Endo International Plc, Lupin Ltd., Merck and Co. Inc., Navinta LLC, Noblepharma Co. Ltd., Panacea Biotec Ltd., Recordati S.p.A, Sanofi, Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., and Tsumura and Co. Also, the Wilson's disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75840

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global wilsons disease drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global wilsons disease drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Chelators - Market size and forecast 2022-2027
Exhibit 34: Chart on Chelators - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Chelators - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Chelators - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Chelators - Year-over-year growth 2022-2027 (%)
6.4 Minerals - Market size and forecast 2022-2027
Exhibit 38: Chart on Minerals - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Minerals - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Minerals - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Minerals - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 48: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 ANI Pharmaceuticals Inc.
Exhibit 111: ANI Pharmaceuticals Inc. - Overview
Exhibit 112: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 113: ANI Pharmaceuticals Inc. - Key offerings
12.4 Apotex Inc.
Exhibit 114: Apotex Inc. - Overview
Exhibit 115: Apotex Inc. - Product / Service
Exhibit 116: Apotex Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 117: AstraZeneca Plc - Overview
Exhibit 118: AstraZeneca Plc - Product / Service
Exhibit 119: AstraZeneca Plc - Key news
Exhibit 120: AstraZeneca Plc - Key offerings
12.6 Bausch Health Co. Inc.
Exhibit 121: Bausch Health Co. Inc. - Overview
Exhibit 122: Bausch Health Co. Inc. - Business segments
Exhibit 123: Bausch Health Co. Inc. - Key news
Exhibit 124: Bausch Health Co. Inc. - Key offerings
Exhibit 125: Bausch Health Co. Inc. - Segment focus
12.7 Breckenridge Pharmaceutical Inc.
Exhibit 126: Breckenridge Pharmaceutical Inc. - Overview
Exhibit 127: Breckenridge Pharmaceutical Inc. - Product / Service
Exhibit 128: Breckenridge Pharmaceutical Inc. - Key offerings
12.8 Dr Reddys Laboratories Ltd.
Exhibit 129: Dr Reddys Laboratories Ltd. - Overview
Exhibit 130: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 131: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 132: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Endo International Plc
Exhibit 133: Endo International Plc - Overview
Exhibit 134: Endo International Plc - Business segments
Exhibit 135: Endo International Plc - Key news
Exhibit 136: Endo International Plc - Key offerings
Exhibit 137: Endo International Plc - Segment focus
12.10 Lupin Ltd.
Exhibit 138: Lupin Ltd. - Overview
Exhibit 139: Lupin Ltd. - Product / Service
Exhibit 140: Lupin Ltd. - Key news
Exhibit 141: Lupin Ltd. - Key offerings
12.11 Merck and Co. Inc.
Exhibit 142: Merck and Co. Inc. - Overview
Exhibit 143: Merck and Co. Inc. - Business segments
Exhibit 144: Merck and Co. Inc. - Key news
Exhibit 145: Merck and Co. Inc. - Key offerings
Exhibit 146: Merck and Co. Inc. - Segment focus
12.12 Navinta LLC
Exhibit 147: Navinta LLC - Overview
Exhibit 148: Navinta LLC - Product / Service
Exhibit 149: Navinta LLC - Key offerings
12.13 Panacea Biotec Ltd.
Exhibit 150: Panacea Biotec Ltd. - Overview
Exhibit 151: Panacea Biotec Ltd. - Product / Service
Exhibit 152: Panacea Biotec Ltd. - Key offerings
12.14 Recordati S.p.A
Exhibit 153: Recordati S.p.A - Overview
Exhibit 154: Recordati S.p.A - Business segments
Exhibit 155: Recordati S.p.A - Key offerings
Exhibit 156: Recordati S.p.A - Segment focus
12.15 Taj Pharmaceutical Ltd.
Exhibit 157: Taj Pharmaceutical Ltd. - Overview
Exhibit 158: Taj Pharmaceutical Ltd. - Product / Service
Exhibit 159: Taj Pharmaceutical Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Tsumura and Co.
Exhibit 165: Tsumura and Co. - Overview
Exhibit 166: Tsumura and Co. - Product / Service
Exhibit 167: Tsumura and Co. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations